Breastcancerchoices.org |
. |
Scrutinizing the evidence for breast cancer procedures and treatments |
. |
Previous Report JUNE 2010 NY TIMES Read Article Lymph Node Dissection Provides No Benefit to Lumpectomy Patients Some 82.2 percent of the women who had the dissection were alive and disease free compared with 83.8 percent of those who did not. Cancer recurred in the breast or nearby in 4.3 percent of those who had the operation and 3.4 percent in those who did not. |
Patients had more distant recurrences with axillary dissection. excerpt from full text To the surprise of most, Fisher's study of 1700 patients failed to reveal any statistically significant survival advantage for patients undergoing ELND. Although the lymph node dissection group experienced fewer recurrences in the treated lymph node basin, this improvement in local control did not translate to a benefit in overall survival. In fact, when these patients did have recurrences, these were more likely to be distant disease. Since Fisher's landmark study, five RCTs evaluating ELND in breast cancer patients have failed to reveal a statistically significant survival advantage for patients treated with ELND.[16] The lack of evidence supporting the value of ELND for breast cancer patients in these five trials raised significant questions regarding the dogmatic but unproven traditional approach to surgical management in patients with cancer. |
Home FAQ Strategies Discussion Iodine Hormones Contact Store |